TRIAL DETAIL

C

Drug:
Trial Name:
C
NCT#:
Conditions:
Gastrointestinal Stromal Tumor
Status:
Active, not recruiting
Phase:
2
Start Date 04/30/2019
Age of Trial (yrs) 6
Treatment Phase:
Gleevec-resistant
Drug Category:
PD-L1 + KIT inhibitor
Strategy:
Trial Type:
Specifically GIST and only GIST
Other Protocol IDs:
AXAGIST
Sponsor:
Maria Sklodowska-Curie Institute - Oncology Center
Patient Contact:
Elzbieta Bylina, MSc 22546 21 03 ext 0048 elzbieta.bylina@coi.pl Katarzyna Kozak, MD 225462172 ext 0048 katarzyna.kozak@coi.pl
Contact email:
Contact Phone:
Randomized:
IV or Oral:
Oral Intravenous
Trial Notes:

Trial Links

Trial Results
 

Drug Information

Trial Sites

Name
Address
City
State
Zip
Country
Warsaw
Poland